AI in Medicine News — 2026-11-01 (Sun) Daily News

Overview

Headlines this period covered clinical decision support (triage and prescriptive tools), documentation and recording tools (including a lawsuit), and drug discovery (new companies and large-vendor moves). On regulation, one FDA AI policy proposal was reported, and calls for legislation and a Pew survey on human oversight appeared. Most headlines give no accuracy figures or evidence stage, so evidence levels are marked "not stated" below.

Diagnosis and imaging

- An AI model for ear infection diagnosis was reported with the wording "may have the diagnosis"; accuracy and evidence stage are not stated (Scienceline). - An AI tool reads abdominal ultrasounds and is described as accelerating emergency diagnoses; the performance figures and evidence stage are not stated (News-Medical). - AZ Med X-ray AI applications are now available on RapidAI's Enterprise Platform; the headline gives no regulatory status or performance figures (Imaging Technology News). - China held a national medical imaging AI competition; results are not stated (Digital Watch Observatory).

Clinical decision support

- DeepMind's intake AI cut under-triage from 30.5% to 12.9%; the setting and study type are not stated (FourWeekMBA). - Prescriptive AI tools are described as shifting critical care toward personalized treatment; evidence stage is not stated (News-Medical). - Doximity launched DoseCheck. A study found that AI recommends costlier care than doctors; study details are not stated (Fierce Healthcare). - DxCheck launched DxPro, an AI-powered clinical intelligence platform for healthcare; no performance data are given (Trend Hunter). - eClinicalWorks projects 30% efficiency gains with AI and Canvas upgrades. This is a company projection, not a measured result (Newsweek). 【Generative AI and clinical documentation】 - A headline describes agentic AI for detecting immune-related adverse events in cancer immunotherapy; performance and evidence stage are not stated (Oncodaily). - Danish GPs see promise in AI voice-to-text notes, with conditions; the conditions are not stated in the headline (Bioengineer.org). - Fangzhou received a Digital Intelligence Leadership Award at a Tencent summit and is expanding its healthcare AI partnership with Tencent Health (markets.businessinsider.com). - An article looks at how AI could cut costs and improve efficiency on a hospital balance sheet; no figures are given in the headline (The Economic Times). 【Hospital operations and care delivery】 - A lawsuit alleges that an AI recording tool used by AHN and Highmark violates patient rights; the case is at the allegation stage (TribLIVE.com). - A Singapore hospital's approach to evaluating AI tools was reported (Healthcare Finance News). - An industry column says another AI divide is already opening in healthcare (Fierce Healthcare). - A newsletter roundup covers a pediatric hospital shortage, patient and LLM decision-making, and federal plan premium increases (Substack). - GeneOnline reports that 7 tech giants are competing and accelerating deployment in the AI biomedical market (GeneOnline). 【Drug discovery and clinical trials】 No headline in this section states a development stage (preclinical, Phase I, etc.). - Anthropic's next big AI business is described as life sciences, from biotech research to drug discovery (Business Insider). - Flagship combined three startups to form the AI-powered drug discovery firm Etcelera (FirstWord Pharma). - An executive left Meta to co-found a drug discovery startup (The American Bazaar). - Manifold AI built a drug discovery MVP on AWS (Amazon Web Services). - An Insilico Medicine leader shared AI-driven drug discovery insights in Shanghai and Dubai (News-Medical). 【Medical device approval and regulation】 - The FDA weekly summary lists a new ConOps for drug inspections and an AI policy proposal. The AI item is a proposal, not an approval, designation or final guidance (RAPS). - Breast cancer surgery AI earned a TIME Best Inventions nod. This is a media recognition, not a regulatory approval; the product name is not given in the headline (The Globe and Mail). - Dartmouth's provost resigned after accusations that they used AI for writing. This is an academic matter, not a medical device or regulatory item (Barchart.com).

Safety, errors and bias

- A headline describes an AI malpractice trap in which clinicians may be sued whether or not they use AI (Medscape). - A headline reports an AI agent autonomously performing a gene therapy injection on a live mouse brain. This is an animal experiment, not human use (The Tech Buzz). - Dr. Vin Gupta said Congress needs to step in and called for regulation of AI in healthcare (KING5.com). - A headline reports a family filing a lawsuit against OpenAI over a ChatGPT death controversy; it is an allegation (Kanak News Odisha). - A Pew survey finds that Americans want human oversight of AI in health care (Fingerlakes1.com). - A headline reports Deep Health AI raising its land acquisition cost to ₹19.50 crore in Pune. It is a business item, not a safety item (scanx.trade). 【Research results (major journals)】 No headline here comes from a major journal; all items are news or trade-press summaries. - A headline reports that an AI-created virus was injected into a human for the first time to fight antibiotic resistance. The headline gives no trial design, safety data or efficacy data, so the evidence stage cannot be assessed from it (Health and Me). - A weekly roundup covers Boehringer, Microsoft, NVIDIA and GSK (Healthcare Digital). - A column argues that mid-revenue-cycle AI must move from transparency to defensibility (Fierce Healthcare).

Developments in Japan

- Google is expanding medical AI collaboration in Singapore, with use in evaluating diagnostic support and in preventive care (Japan's Zaikei Shimbun). - A sleep AI in Musashimurayama is reported not to require dedicated equipment but cannot be used for diagnosis (quasa.io). - Kurashiki Central Hospital and SUNABACO co-hosted Setouchi MED Innovation Conference, an event on generative AI and citizen development, with healthcare staff at the center (Sanyo Shimbun). - Two other items are not medical: a horse-racing AI forecast (SPAIA Keiba) and a test of AI personality diagnosis whose results changed with language (GIGAZINE).

Statements by key figures

No notable developments. The tracked list was empty this period. A statement by Dr. Vin Gupta is covered in section 8.